Navigation Links
The Scripps Research Institute Names Michael A. Marletta as President
Date:2/25/2011

LA JOLLA, Calif., Feb. 25, 2011 /PRNewswire/ -- Renowned biochemist Michael A. Marletta, PhD, has been named by the Board of Trustees today as the next president of The Scripps Research Institute, effective January 1, 2012. He will succeed President Richard A. Lerner, MD, who has led the institution for 25 years.

Image available at: http://www.scripps.edu/news/press/images/20110220_marletta/marletta_m.jpg

Marletta, past Chair of the Department of Chemistry, Co-Director of the Chemical Biology Graduate Program, Aldo DeBenedictis Distinguished Professor of Chemistry and Professor of Biochemistry in the Department of Molecular and Cell Biology at the University of California (UC), Berkeley, will join the Scripps Research faculty on July 1, 2011, and become President and CEO January 1, 2012.

"We are thrilled Michael is assuming this important role," said Dick Gephardt, President/CEO of Gephardt Government Affairs and Lead Trustee of the Scripps Research Board of Trustees. "We are confident Michael's leadership and vision will ensure the Institute's continued preeminence in biomedical research and graduate education."

"I am honored to be named to lead one of the premier research institutions in the world," said Marletta. "Richard Lerner's leadership over the past 25 years has been nothing short of brilliant. His accomplishments as President coupled with a long and distinguished research career, are simply amazing. In addition to my excitement about being asked to serve as president, I am thrilled about moving my research program to Scripps Research and working with my new Scripps Research colleagues to push forward the Institute's legacy of creating knowledge, improving healthcare, and educating the next generation of scientists."

Like The Scripps Research Institute as a whole, Marletta—a former recipient of the prestigi
'/>"/>

SOURCE Scripps Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
5. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
6. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
7. Video: New Research Discovers Independent Brain Networks Control Human Walking
8. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
9. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
10. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and medical device ... and the United States , today ... Tel Aviv area of Israel.  ... broad platform of integrated R&D services to local customers. ...
(Date:10/30/2014)...   ViaDerma, Inc. (OTCQB: VDRM), a ... to market, has recently released a revolutionary new ... topical liquid tetracycline-based antibiotic that uses a patent-pending ... medication active ingredients into topical drugs. The drug ... to help prevent skin infection in minor cuts, ...
(Date:10/30/2014)... , Oct. 30, 2014 Molecular Profiles Ltd., ... CBRX ) and Maryland -based Xceleron ... improved efficiency during clinical development that will be launched ... next week. This partnership extends Molecular Profiles, ... it launched earlier this month. The company also has ...
Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
(Date:10/30/2014)... Reinberg HealthDay Reporter , WEDNESDAY, ... men with prostate cancer who also have certain heart problems ... a new study suggests. , , The therapy in question is ... to reduce levels of male hormones to prevent the growth ... current research, this hormone therapy was linked to triple the ...
(Date:10/30/2014)... Horse Sense & Sensitivity ... special needs individuals in the Jacksonville area, will be ... from 10-2:00 p.m. at Bailey's Farm (2202 Bishop Estates ... public and is designed to raise awareness and funds ... HSS Round-Up is free. Ticket purchases will be required ...
(Date:10/30/2014)... New York (PRWEB) October 30, 2014 ... Society (NAMS) came to a close on Saturday, ... meeting since the Society’s inception in 1989. NAMS is ... health and quality of life of all women during ... healthy aging. With over 2,000 physicians and thought leaders ...
(Date:10/30/2014)... Amy Norton HealthDay ... Exposure to a common plastics, chemical during pregnancy may have ... hints. Researchers found that baby boys born to moms ... have a shorter anogenital distance -- the space between the ... and it,s considered a marker of exposure to androgens ("male" ...
(Date:10/30/2014)... Oct. 29, 2014 (HealthDay News) -- A new vaccine ... meningococcal disease was approved by the U.S. Food and ... protect people between the ages of 10 and 25 ... serogroup B bacteria. The bacteria can infect ... spinal cord and brain. It is a leading cause ...
Breaking Medicine News(10 mins):Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2
... four randomized controlled trials that directly compared two different ... radiofrequency ablation (RFA) significantly improves patient survival compared to ... findings are in the February issue of Hepatology ... on behalf of the American Association for the Study ...
... women who should receive radiation after a mastectomy are ... new study from researchers at the University of ... women who were treated with a mastectomy for breast ... who fell clearly within guidelines recommending radiation treatment after ...
... one million families by offering an economic opportunity in ... Corporation Chairman and CEO Roger Barnett will launch a ... support to one million families in 2009. The ... "Families are struggling to make ends meet in ...
... WASHINGTON, Feb. 3 Green tea products have become ... shown evidence of its benefit against a variety of ... some components of green tea may counteract the anticancer ... be contraindicated for patients taking this medicine to ensure ...
... Feb. 3 America,s oldest voluntary health organization is ... Nolan. Elected National Board Chair, after more than a ... has successfully steered the American Lung Association to tackle ... emphasis of his chairmanship has been to build on ...
... to increased mortality, , , TUESDAY, Feb. 3 (HealthDay News) -- ... needs to be taken seriously, a new study concludes. , ... goes up for at least five years following any low-trauma ... fracture. , "All low-trauma fractures are associated with premature mortality, ...
Cached Medicine News:Health News:Radiofrequency treatment better than ethanol injection for small liver tumors 2Health News:U-M Study: 19% of Breast Cancer Patients Don't Receive Recommended Radiation After Mastectomy 2Health News:Shaklee Hits the Road With Its Infinite Possibilities Tour 2Health News:Green Tea May Negate the Effects of a Common Cancer Therapy 2Health News:Green Tea May Negate the Effects of a Common Cancer Therapy 3Health News:Green Tea May Negate the Effects of a Common Cancer Therapy 4Health News:Maryland Lawyer Steve Nolan Advocates for Lung Health as National Board Chair of the American Lung Association 2Health News:Fractures in Older Adults Up Death Risk 2
... prisms are of superior quality. Set of 16 includes 1/2, ... 35, 40, 45, and 50 diopter plus Red Lens. Each ... lbs)., , 4445xx , ,These prisms are of superior quality. ... 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, ...
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
... PC is the most powerful Isolated ESU on ... It is the only ESU that allows the ... field with a standard ES pencil. Excalibur Plus ... minimum necessary voltage for smooth cutting through various ...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
Medicine Products: